Annual Congress Copenhagen 2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

Material from 2005: Show

Oral Presentation
Chairs: P. E. Postmus (Amsterdam, The Netherlands), R. Huber (Munich, Germany)

Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer A. Gröschel, D. Hellwig, T. Graeter, D. Ukena, H. J. Schäfers, C. M. Kirsch, G. W. Sybrecht (Homburg, Germany)
Management of bone metastases (BM): results of a large multinational, multidisciplinary survey J. Guigay, J. Y. Bobin, J. L. Lagrnage, J. D. Laredo, M. Tubiana-Hulin, J. J. Body, the GEMO (Groupe Européen francophone d'étude des Métastases Osseuses) (Clamart, Lyon, Créteil, Paris, Saint-Cloud, France; Brussels, Belgium)
Stenting in malignant superior vena caval obstruction: an eight year experience in a district general hospital R. Santhanakrishnan, C. George, C. Prys-Pickard, P. Woodhead, F. Zaman (Burnley, United Kingdom)
Age and stage at presentation in lung cancer J. R. Ramsay, N. Turner, M. Muers (Leeds, United Kingdom)
Delays in lung cancer management H. Koyi, G. Hillerdal, E. Brandén (Stockholm, Sweden)
Predictors of major serious manifestations in the terminal stage of lung cancer K. Skaug, G. E. Eide, A. Gulsvik (Haugesund, Bergen, Norway)
TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas A. Rigas, N. Maouni, N. Trakas, P. Stylianou, E. Dimopoulou, A. Kotanidou, M. Chorti, P. Ziotopoulos, D. Orphanidou, F. Palamidas (Athens, Greece)